Company Overview and News
DUBLIN, Calif., July 02, 2018 (GLOBE NEWSWIRE) -- TriNet Group, Inc. (NYSE:TNET), a leading provider of comprehensive human resources solutions for small to midsize businesses, today announced that on July 1, 2018 the Internal Revenue Service (IRS) designated a TriNet subsidiary as a Certified Professional Employer Organization (CPEO). CPEO is a federal certification program managed by the IRS that compliments existing state licensing programs for PEOs, like TriNet.
DUBLIN, Calif., June 04, 2018 (GLOBE NEWSWIRE) -- TriNet (NYSE:TNET), a leading provider of HR services, introduced today TriNet Professional Services, its newest industry-specific product designed to address the unique HR needs of professional services firms, such as consulting, advertising and other expertise-driven industries. Recently named the best HR outsourcing product for industry-specific solutions as part of Inc.
Automatic Data Processing, Inc. (ADP - Free Report) stock has rallied a massive 28.9% in the past year, outperforming the S&P 500’s gain of 13.7%. The company is well poised on the back of strategic acquisitions and strong cash generation ability. ADP’s focus on streamlining its business is a positive as this should strengthen its core operations in the long run.
ADPVV ADP BR TNET
The portfolio continues to be very concentrated with the top five positions accounting for ~30% of the 13F portfolio.
FB SERV AMT.PRB AMT.PRA IBKR CMPR GOOG MHFI SPGI AMT CME AGN SSNC AVGO WSH ICE FIS BIDU CBRE TSM ECL ST EFX A BDX VRSN WLTW ZTS AON V 7018 CBG PRI GOOGL CACC ADI BITA BRCM TNET
DUBLIN, Calif., May 07, 2018 (GLOBE NEWSWIRE) -- TriNet (NYSE:TNET), a leading provider of comprehensive HR services today announced that Olivier Kohler has joined the company as senior vice president and chief operations officer. Reporting directly to Burton M. Goldfield, TriNet’s president and chief executive officer, Kohler will lead TriNet’s client services and service operations teams—both major functions of the TriNet client experience.
Good afternoon. And welcome to the TriNet Group Inc. First Quarter 2018 Earnings Conference Call. All participants will be in listen-only mode. [Operator Instructions] After today's presentation, there will be an opportunity to ask questions. [Operator Instructions] Please note this event is being recorded.
SF SFN SFB DIS TNET SF.PRA
The Business Services sector covers an array of services including marketing, consulting, staffing, security, telecommunications, Internet services, logistics and waste handling. Thus, the outlook of the business services sector is firmly tied to the broader economy.
AMKR FDC TBI NSP SAH TNET
8h - Asif
History and Development of the Company Kitov Pharma was incorporated under the laws of the State of Israel (under a previous name) on August 12, 1968 and its ordinary shares were originally listed for trading on the TASE in 1978. The company's ordinary shares are currently traded on the TASE under the symbol “KTOV”, and its ADSs and its public warrants are traded on NASDAQ under the symbols “KTOV” and “KTOVW”, respectively. In October 2012, the District Court in Lod, Israel approved the creditors arrangement in accordance with Section 350 of the Companies Law in order to effectuate the sale by Kitov Pharma (then known as Mainrom Line Logistics Ltd.) of all its activities, assets, rights, obligations and liabilities to a private company held by its then controlling shareholders, and all rights of Kitov Pharma’s creditors against it were extinguished. The sale was made pursuant to an arrangement between Kitov Pharma and its creditors. Following such sale and a related cash...
9h - Asif
Overview and Recent Developments Athersys is an international biotechnology company that is focused primarily in the field of regenerative medicine. The company's MultiStem® cell therapy, a patented and proprietary allogeneic stem cell product, is its lead platform product and is currently in later-stage clinical development. The company's current clinical development programs are focused on treating neurological conditions, cardiovascular disease, inflammatory and immune disorders, certain pulmonary conditions and other conditions where the current standard of care is limited or inadequate for many patients, particularly in the critical care segment. Current Programs By applying its proprietary MultiStem cell therapy product, the company established therapeutic product development programs treating neurological conditions, cardiovascular disease, inflammatory and immune disorders, and other conditions. The company's programs in the clinical development stage include ...
2018-07-16 - Asif
General The company's objective is to build a profitable and growing specialty therapeutics company. To meet this objective, Cytori Therapeutics has acquired and are developing two technology platforms that hold promise for treating millions of patients and represent significant potential for increasing shareholder value. The company's current corporate activities fall substantially into advancing these platforms: Cytori Nanomedicine and Cytori Cell Therapy. The Cytori Nanomedicine platform features a versatile liposomal nanoparticle technology for drug encapsulation that has thus far provided the foundation to bring two promising drugs into mid/late stage clinical trials. Nanoparticle encapsulation is promising because it can help improve the delivery and metabolism of many drugs, thus potentially enhancing the therapeutic profile and patient benefits. The company's lead drug candidate, ATI-0918 is a generic version of pegylated liposomal encapsulated doxorubicin. Pegyl...
Silicon Investor Message Boards
This table lists all message boards related to TNET / TriNet Group, Inc. on message board site Silicon Investor.
|STTC - SoftNet Technology Corporation||NextNet, Inc - Wireless DSL ( ZMBA )|
|EINI -- Entertainment Internet (CastNet)||Fastnet IPO|
|Softnet Industries Internet casino and Bingo supersites||Softnet moves to Nasdaq|
|MUNDER NETNET FUND|
as of ET